SLU-PP-332, 5mg

SLU-PP-332 

Quick Overview (TL;DR)
SLU-PP-332 is an experimental compound that researchers are studying because it can activate a protein called PPAR delta, which helps control how the body burns fat and builds muscle. In animal studies, it has shown promise for improving endurance, reducing fat, and supporting metabolic health. It’s not approved for any medical use and is only used in laboratory research at this time.

Detailed Scientific Description
What is SLU-PP-332?
SLU-PP-332 is an investigational small molecule agonist of the peroxisome proliferator-activated receptor delta (PPARδ). This nuclear receptor plays a central role in regulating lipid metabolism, energy expenditure, and muscle fiber composition. SLU-PP-332 is primarily used in preclinical studies to explore new treatments for obesity, metabolic syndrome, and muscle-wasting disorders.

How It Works (Mechanism of Action)
SLU-PP-332 works by binding to and activating PPARδ, leading to:

• Enhanced Fat Metabolism
• Increases the body’s ability to oxidize fatty acids for energy, reducing fat storage.
• Improves metabolic flexibility during exercise and fasting.
• Muscle Fiber Remodeling
• Shifts muscle fibers toward oxidative (Type I) fibers, which are more fatigue resistant.
• Supports greater endurance capacity in animal models.
• Anti-Inflammatory and Metabolic Effects
• May reduce markers of inflammation linked to metabolic disease.
• Improves insulin sensitivity in experimental settings.
• Potential Benefits & Research Applications
• Increased Endurance: Animal studies show improved exercise capacity and stamina.
• Reduced Fat Accumulation: Promotes fat burning and may lower body weight in preclinical models.
• Improved Metabolic Health: Supports better glucose control and lipid profiles in lab research.
• Muscle Preservation: Potential applications in sarcopenia (age-related muscle loss) and cachexia.
• Exploratory Uses: Being studied as a model compound for PPARδ-targeted therapies.

Typical Dosage & Administration

• Administration: Used only in laboratory settings, typically via oral gavage or injection in animal studies.
• Dosage: No standardized dosing in humans. In rodents, research doses range from 5–30 mg/kg, depending on experimental design.

Possible Side Effects

• Unknown in Humans: No human safety data is available.
• Animal Study Observations:
• Potential for liver enzyme elevations with chronic use.
• Possible impacts on lipid metabolism markers.

SLU-PP-332 is strictly for research purposes and is not approved for any therapeutic applications.

Often used to investigate metabolic and exercise-related pathways in preclinical studies.

Must be handled and stored under laboratory protocols for investigational compounds.